The effects of deferasirox on renal, cardiac and hepatic iron load in patients with β-thalassemia major: Preliminary results

Pediatric Hematology and Oncology

Volumn 28, Issue 3, 2011, Pages 217-221

  Unal, Sule ^a   Hazirolan, Tuncay ^a   Eldem, Gonca ^a   Gumruk, Fatma ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

deferasirox; MRI; nefrotoxicity; renal; T2*

Indexed keywords

CREATININE; DEFERASIROX; FERRITIN; IRON;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMORBIDITY; CREATININE BLOOD LEVEL; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEART; HUMAN; IRON CHELATION; KIDNEY; LIVER; MALE; NEPHROTOXICITY; SCHOOL CHILD; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BENZOIC ACIDS; BETA-THALASSEMIA; CHILD; FEMALE; HEART; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; KIDNEY; LIVER; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 79952495608     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.522230     Document Type: Article

References (23)

1. ®, ICL670) preclinical overview. Semin Hematol. 2007;44:12-15.
2. Cappellini MD, Pattoneri P. Oral iron chelators. Annu Rev Med. 2009;60:25-38.
3. Nick H Acklin P, Lattmann R, et al. Development of tridentate iron chelators: from desferrithiocinto ICL670. CurrMed Chem. 2003;10:1065-1076. (Pubitemid 36582249)
4. Nick H, Wong A, Acklin P, et al. ICL670A: preclinical profile. Adv Exp Med Biol. 2002;509:185-203. (Pubitemid 37526718)
5. Cappellini MD, Cohen A, Piga A, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455-3462.
6. ® (deferasirox) summary of product characteristics. Available at: http://www.ema.europa.eu/docs/en-GB/ document-library/EPAR-Product-Information/human/000670/WC500033925.pdf. Access date: 6 November 2010.
7. Brosnahan G, Gokden N, Swaminathan S. Acute interstitial nephritis due to deferasirox: a case report. Lancet 2008;2:27-30.
8. Rafat C, Fakhouri F, Ribeil JA, et al. Fanconi syndrome due to deferasirox. Am J Kidney Dis. 2009;54:931-934.
9. Sumboonnanonda A, Malasit P, Tanphaichitr VS, et al. Renal tubular function in beta-thalassemia. Pediatr Nephrol. 1998;12:280-283.
10. * to oral deferasirox monotherapy for 1 year in 29 patients with transfusion-dependent anaemias; a subgroup analysis. Haematologica. 2006;91(Suppl 1):Abstract 999.
11. Buckalew VM Jr, Someren A. Renal manifestations of sickle cell disease. Arch Intern Med. 1974;133:660-669.
12. Lande IM, Glazer GM, Sarnaik S, et al. Sickle-cell nephropathy: MR imaging. Radiology. 1986;158:379-383. (Pubitemid 16160599)
13. Solecki R, von Zglinicki T, Muller HM, Clausing P. Iron overload of spleen, liver and kidney as a consequence of hemolytic anaemia. Exp Pathol. 1983;23:227-235. (Pubitemid 13056038)
14. Tracz MJ, Alam J, Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol. 2007;18:414-420. (Pubitemid 46193307)
15. Gburek J, Verroust PJ, Willnow TE, et al. Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J Am Soc Nephrol. 2002;13:423-430. (Pubitemid 34110430)
16. Jeong JY, Kim SH, Lee HJ, Sim JS. Atypical low-signal-intensity renal parenchyma: causes and patterns. Radiographics. 2002;22:833-846.
17. Schein A, Enriquez C, Coates TD, Wood JC. Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis. J Magn Reson Imaging. 2008;28:698-704.
18. Chalevelakis G, Clegg JB, Weatherall DJ. Imbalanced globin chain synthesis in heterozygous betathalassemic bone marrow. Proc Natl Acad Sci USA. 1975;72:3853-3857.
19. Buhl L, Muirhead DE, Prentis PF. Renal hemosiderosis due to thalassemia: a light and electron microscopy study with electron probe X-ray microanalysis. Ultrastruct Pathol. 1993;17:169-183. (Pubitemid 23165324)
20. Koliakos G, Papachristou F, Koussi A, et al. Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia. Clin Lab Haematol. 2003;25:105-109. (Pubitemid 36458159)
21. Link G, Athias P, Grynberg A, et al. Effect of iron loading on transmembrane potential, contraction, and automaticity of rat ventricular muscle cells in culture. J Lab Clin Med. 1989;113:103-111. (Pubitemid 19035190)
22. Tomas CE, Morehouse LA, Aust SD. Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem. 1985;260:3275-3280. (Pubitemid 15115239)
23. Aldudak B, Karabay Bayazit A, Noyan A, et al. Renal function in pediatric patients with betathalassemia major. Pediatr Nephrol. 2000;15:109-112.